Renub Research study titled “Alzheimer’s Pipeline Drugs Review, Alzheimer’s Disease Drug Market & Forecast – Global Analysis” provides a comprehensive assessment of the fast-evolving, high-growth Global Alzheimer’s Disease Market. This 110 page report with 29 Figures and 11 Tables studies the Global Alzheimer’s Disease Drug Market. <br /> <br />Present & Pipeline Drugs Studied in this Report <br /> <br />1. Namenda <br />2. Ebixa <br />3. Axura <br />4. Aricept <br />5. Nootropil <br />6. Exelon <br />7. Memary <br />8. Solanezumab <br />9. LuAe58054 <br /> <br />This report contains 10 chapters. <br /> <br />(Chapter 1): Executive Summary <br /> <br />(Chapter 2): This Chapter is divided into 2 parts <br /> <br />A. Alzheimer’s Disease Drug Market & Forecast data available from 2003 to 2018 <br /> <br />B. Unmet Alzheimer’s Disease Drug Market & Forecast (Market Potential) data available from 2010 to 2018. (Unmet market is the potential market which could have been achieved if right drug have been introduced in the market) <br /> <br />(Chapter 3): This chapter talks about drugs which has failed while in Clinical trials <br /> <br />(Chapter 4): This chapter provides Market Share of Alzheimer’s Disease Drug from 2003 to 2018. All the 9 Alzheimer’s drug mentioned above have been covered in this chapter. <br /> <br />(Chapter 5): This chapter talks about Alzheimer’s Drugs performance. All important drugs mentioned above past, present & future market data available from 2003 to 2018. <br /> <br />(Chapter 6): Pipeline drugs (Solanezumab, LuAE58054, Gantenerumab, Crenezumab, TRx0237 (LMTX), MK-8931, ABT-126, AZD-1446) have been analyzed in this chapter. All drugs have been analyzed from 5 view points: <br /> <br />A. Clinical Development Stage <br />B. Pipeline Drug Sales Performance <br />C. Recent Clinical Development <br />D. Different Companies Deal <br />E. Investment <br /> <br />(Chapter 7): This chapter speaks of Alzheimer’s Drugs Company deals in four areas <br /> <br />A. Strategic Alliances in Alzheimer’s Disease Drug Market <br />B. Licensing Agreement in Alzheimer’s Disease Drug Market <br />C. Collaboration Deal in Alzheimer’s Disease Drug Market <br />D. Merger & Acquisition in Alzheimer’s Disease Drug Market <br /> <br />(Chapter 8): This chapter studies Funding in Alzheimer’s Disease Drugs Research. We have covered 5 institutes which provides fund for the research. <br /> <br />A. National Institute of Health <br />B. Alzheimer's Association <br />C. Cure Alzheimer’s Fund <br />D. Alzheimer’s Drug Discovery Foundation <br />E. BrightFocus Foundation [formerly American Health Assistance Foundation (AHAF)] <br /> <br />(Chapter 9): This chapter studies Growth Factors Driving the Alzheimer’s Disease Drug Market. <br /> <br />(Chapter 10): This chapter studies Challenges/Hindrances faced by Alzheimer’s Disease Drug Market. <br /> <br />Contact Us <br /> <br />Andy Hill <br />Sr. Manager - Publisher Relation <br />Sales & Marketing Div. <br />Renub Research <br />Email: info@renub.com <br />Phone: +1-678-302-0700 (USA) , +91-120-4219-822, +91-120-254-5750 (India) <br />Web: http://www.renub.com/
